Soltani S, Zandi M, Fani M, Zakeri A, Pakzad R, Salmanzadeh S
Malawi Med J. 2025; 36(3):179-184.
PMID: 40018397
PMC: 11862852.
DOI: 10.4314/mmj.v36i3.4.
Tarahomi M, Shokri Koohikheyli M, Pooya P, Eslami M, Vakili M, Habibian F
Med J Islam Repub Iran. 2025; 38:101.
PMID: 39968478
PMC: 11835408.
DOI: 10.47176/mjiri.38.101.
Golpour M, Jalali H, Alizadeh-Navaei R, Rezaei Talarposhti M, Mousavi T, Ghara A
BMC Infect Dis. 2025; 25(1):145.
PMID: 39891054
PMC: 11783914.
DOI: 10.1186/s12879-025-10521-5.
Varshney K, Pillay P, Mustafa A, Shen D, Adalbert J, Mahmood M
Clin Exp Med. 2023; 23(7):3265-3275.
PMID: 37326928
PMC: 10618381.
DOI: 10.1007/s10238-023-01116-y.
Maltezou H, Papanikolopoulou A, Vassiliu S, Theodoridou K, Nikolopoulou G, Sipsas N
Viruses. 2023; 15(4).
PMID: 37112844
PMC: 10142898.
DOI: 10.3390/v15040865.
Vaccines and cardiovascular outcomes: lessons learned from influenza epidemics.
Yedlapati S, Mendu A, Tummala V, Maganti S, Nasir K, Khan S
Eur Heart J Suppl. 2023; 25(Suppl A):A17-A24.
PMID: 36937374
PMC: 10021491.
DOI: 10.1093/eurheartjsupp/suac110.
An integrated dual-layer microfluidic platform for multiple respiratory viruses screening.
Wang H, Xu J, Li S, Wang X, Liu G, Yang S
Anal Chim Acta. 2023; 1242:340812.
PMID: 36657884
PMC: 9822946.
DOI: 10.1016/j.aca.2023.340812.
Prospective, randomised, parallel-group, open-label study to evaluate the effectiveness and safety of IMU-838, in combination with oseltamivir, in adults with COVID-19: the trial protocol.
Sharma K, Berry L, Vryonis E, Ali A, Lara B, Noufaily A
BMJ Open. 2022; 12(11):e055205.
PMID: 36396307
PMC: 9676417.
DOI: 10.1136/bmjopen-2021-055205.
Bacterial Co-Infection in Patients with COVID-19 Hospitalized (ICU and Not ICU): Review and Meta-Analysis.
Santos A, Goncalves L, Oliveira A, Queiroz P, Ito C, Santos M
Antibiotics (Basel). 2022; 11(7).
PMID: 35884147
PMC: 9312179.
DOI: 10.3390/antibiotics11070894.
A Game of Infection - Song of Respiratory Viruses and Interferons.
Wang G, Gu Y, Wang C, Wang F, Chen-Yu Hsu A
Front Cell Infect Microbiol. 2022; 12:937460.
PMID: 35846766
PMC: 9277140.
DOI: 10.3389/fcimb.2022.937460.
Case Report: Co-infection with SARS-CoV-2 and influenza H1N1 in a patient with acute respiratory distress syndrome and a pulmonary sarcoidosis.
Baala L, Benzekri-Lefevre D, Bret L, Guillaume C, Courtellemont L, El Khalil A
F1000Res. 2022; 9:1482.
PMID: 35528205
PMC: 9065929.
DOI: 10.12688/f1000research.26924.2.
New substitutions on NS1 protein from influenza A (H1N1) virus: Bioinformatics analyses of Indian strains isolated from 2009 to 2020.
Lubna S, Chinta S, Burra P, Vedantham K, Ray S, Bandyopadhyay D
Health Sci Rep. 2022; 5(3):e626.
PMID: 35509388
PMC: 9059196.
DOI: 10.1002/hsr2.626.
Viral Etiological Agent(s) of Respiratory Tract Infections in Symptomatic Individuals during the Second Wave of COVID-19 Pandemic: A Single Drive-Thru Mobile Collection Site Study.
Kozinska A, Wegrzynska K, Komiazyk M, Walory J, Wasko I, Baraniak A
Pathogens. 2022; 11(4).
PMID: 35456150
PMC: 9030165.
DOI: 10.3390/pathogens11040475.
SARS-CoV-2 and influenza viruses: Strategies to cope with coinfection and bioinformatics perspective.
Ghaznavi H, Shirvaliloo M, Sargazi S, Mohammadghasemipour Z, Shams Z, Hesari Z
Cell Biol Int. 2022; 46(7):1009-1020.
PMID: 35322909
PMC: 9083817.
DOI: 10.1002/cbin.11800.
The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape.
Souza P, Mesquita F, Amaral J, Landim P, Lima K, Costa M
Int J Biol Macromol. 2022; 208:105-125.
PMID: 35300999
PMC: 8920968.
DOI: 10.1016/j.ijbiomac.2022.03.058.
SARS-CoV-2 and influenza virus coinfection among patients with severe acute respiratory infection during the first wave of COVID-19 pandemic in Bangladesh: a hospital-based descriptive study.
Akhtar Z, Islam M, Aleem M, Mah-E-Muneer S, Ahmmed M, Ghosh P
BMJ Open. 2021; 11(11):e053768.
PMID: 34845073
PMC: 8634662.
DOI: 10.1136/bmjopen-2021-053768.
A Case Series of SARS-CoV-2 and Influenza Co-infection.
Ali R, Patel A, Chan K, Veeraballi S, Slim J
Cureus. 2021; 13(8):e17597.
PMID: 34646649
PMC: 8482808.
DOI: 10.7759/cureus.17597.
COVID-19 and Pulmonary Mycobacterium Tuberculosis Coinfection.
Al Lawati R, Al Busaidi N, Al Umairi R, Al Busaidy M, Al Naabi H, Khamis F
Oman Med J. 2021; 36(5):e298.
PMID: 34631157
PMC: 8477439.
DOI: 10.5001/omj.2022.23.
Co-infection between the severe acute respiratory syndrome coronavirus 2 and the influenza Type B in Isfahan, Iran.
Heshmat-Ghahdarijani K, Vaseghi G, Nasirian M, Javanmard S
J Res Med Sci. 2021; 26:51.
PMID: 34484383
PMC: 8384011.
DOI: 10.4103/jrms.JRMS_820_20.
COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis.
Dadashi M, Khaleghnejad S, Elkhichi P, Goudarzi M, Goudarzi H, Taghavi A
Front Med (Lausanne). 2021; 8:681469.
PMID: 34249971
PMC: 8267808.
DOI: 10.3389/fmed.2021.681469.